19th week of 2010 patent applcation highlights part 53 |
Patent application number | Title | Published |
20100120887 | SUSTAINED RELEASE FORMULATION OF MELATONIN - The present invention relates to low-dose formulations of melatonin, and methods of use thereof, which provide a sustained release of melatonin so as to rapidly increase plasma levels of melatonin, maintain a relatively high level (which mimics the endogenous level of a young subject) for approximately 5-6 hours, and then decrease so as to achieve low levels by early morning (rapid washout), thereby avoiding a “hangover effect”. The sustained release formulations of the invention may be used to treat a variety of sleep-related disorders, including, but not limited to, delayed onset and maintenance forms of insomnia. | 2010-05-13 |
20100120888 | ATORVASTATIN STRONTIUM SALT AND PHARMACEUTICAL COMPOSITION COMPRISING SAME - This invention provides atorvastatin strontium salt or its hydrates or polymorphs having improved water solubility, which is useful for the prevention or treatment of hyperlipidemia and hypercholesterolemia, and a pharmaceutical composition comprising same. | 2010-05-13 |
20100120889 | SKIN CARE COMPOSITION FOR ACCELERATED PRODUCTION OF COLLAGEN PROTEINS AND METHOD OF FABRICATING THE SAME - A liquid solution for topical application to the skin of an animal consists of solutes and a solvent, where the solutes include ascorbate, tropocollagen factors, copper, and zinc gluconate. The tropocollagen factors include L-proline, glycine and L-lysine. | 2010-05-13 |
20100120890 | ION CHANNEL MODULATING ACTIVITY I - Methods, compositions, dosing regimes, and routes of administration for the treatment or prevention of arrhythmias. In these methods, early afterdepolarizations and prolongation of QT interval may be reduced or eliminated by administering ion channel modulating compounds to a subject in need thereof. The ion channel modulating compounds may be cycloalkylamine ether compounds, particularly cyclohexylamine ether compounds. Also described are compositions of ion channel modulating compounds and drugs which induce early afterdepolarizations, prolongation of QT interval and/or Torsades de Pointes. | 2010-05-13 |
20100120891 | USE OF A GALECTIN-1-TARGETED RNAI-BASED APPROACH FOR THE TREATMENT OF CANCER - The present invention relates to an RNAi molecule suitable for reducing the expression of galectin-1 containing any of the sequences of SEQ ID NOs: 1-33, and preferably the sequences of SEQ ID NO: 2, 3, or 4, and to the use thereof as a medicament, or for the manufacture of a medicament for treating and/or for delaying the progression of cancer, preferably glioma, pancreatic cancer, head and neck cancer, melanoma, non-small-cell lung cancer and non-Hodgkin's lymphoma. The present invention also relates to compositions and methods for treating and for delaying the progression of cancer, preferably glioma, pancreatic cancer, head and neck cancer, melanoma, non-small-cell lung cancer and non-Hodgkin's lymphoma, for reducing the migration of tumor cells, preferably cells of glioma, pancreatic cancer, head and neck cancer, melanoma, non-small-cell lung cancer and non-Hodgkin's lymphoma, and/or for enhancing the efficacy of cancer therapies for the treatment of cancer, preferably glioma, pancreatic cancer, head and neck cancer, melanoma, non-small-cell lung cancer and non-Hodgkin's lymphoma, selected from the group comprising chemotherapy, radiation therapy, immunotherapy, and/or gene therapy. | 2010-05-13 |
20100120892 | METHODS AND COMPOSITIONS FOR THE INHIBITION OF STAT5 IN PROSTATE CANCER CELLS - The present invention relates to compositions and methods for the treatment of prostate cancer. In certain embodiments, the invention relates to compositions and methods for the inhibition of prostate cancer cell growth, comprising inhibiting the activity of Stat5 in prostate cancer cells. | 2010-05-13 |
20100120893 | Compositions and Methods for Inhibiting Expression of Transthyretin - The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting a transthyretin (TTR) gene, and methods of using the dsRNA to inhibit expression of TTR. | 2010-05-13 |
20100120894 | Intracellular DNA receptor - Provided herein are methods of identifying and using compounds that modulate an AIM2 polypeptide-mediated immune response. Further provided herein are methods of treating disease comprising administering to a patient a compound that decreases expression of an AIM2 polypeptide. Further provided herein are methods of providing gene therapy to a patient comprising administering to the patient a gene therapy agent and a compound that decreases expression of an AIM2 polypeptide. In certain embodiments, a compound that decreases expression of an AIM2 polypeptide comprises an siRNA or an shRNA. | 2010-05-13 |
20100120895 | RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA) - The present invention relates to compounds, compositions, and methods for the study, diagnosis, and treatment of traits, diseases and conditions that respond to the modulation of cyclic nucleotide type 4 phosphodiesterase (PDE4B) gene expression and/or activity, including PDE4B1, PDE4B2, and PDE4B3 gene expression and/or activity. The present invention is also directed to compounds, compositions, and methods relating to traits, diseases and conditions that respond to the modulation of expression and/or activity of genes involved in cyclic nucleotide type 4 phosphodiesterase (PDE4B) gene expression pathways or other cellular processes that mediate the maintenance or development of such traits, diseases and conditions, including but not limited to IL-6, IL-7, IL-8, IL-15, TNF-alpha and matrix metalloproteinases (MMPs), such as MMP-I, MMP-2, MMP-3, MMP-9 and MMP-12. Specifically, the invention relates to double stranded nucleic acid molecules including small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA), and multifunctional siNA molecules capable of mediating RNA interference (RNAi) against cyclic nucleotide type 4 phosphodiesterase (PDE4B) gene expression, including cocktails of such small nucleic acid molecules and lipid nanoparticle (LNP) formulations of such small nucleic acid molecules. The present invention also relates to small nucleic acid molecules, such as siNA, siRNA, antisense and others that can inhibit the function of endogenous RNA molecules or RNAi pathway components (RNAi inhibitors), such as endogenous micro-RNA (miRNA) (e.g, miRNA inhibitors) or endogenous short interfering RNA (siRNA), (e.g., siRNA inhibitors) or that can inhibit the function of RISC (e.g., RISC inhibitors), to modulate PDE4B gene expression by interfering with the regulatory function of such endogenous RNAs or proteins associated with such endogenous RNAs (e.g., RISC) including cocktails of such small nucleic acid molecules and lipid nanoparticle (LNP) formulations of such small nucleic acid molecules. Such small nucleic acid molecules are useful, for example, in providing compositions to prevent, inhibit, or reduce inflammatory, respiratory, and autoimmune diseases, traits, and conditions, and/or other disease states associated with PDE4B gene expression or activity in a subject or organism. | 2010-05-13 |
20100120896 | Once-A-Day RNA-Polymerase inhibiting and elongation factor G (EF-G) inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by methicillin-resistant staphylococcus aureus - Disclosed are once-a-day antibiotic products for treating Methicillin-Resistant | 2010-05-13 |
20100120897 | NOVEL HELPER PLASMID, DEFECTIVE SINDBIS VIRAL VECTORS AND METHODS OF USE THEREOF - Disclosed herein are new defective Sindbis viral vectors made from a novel Helper plasmid, with differences in envelope proteins between JT vectors and consensus Sindbis virus sequences, and also between JT and Ar-339 vectors. Also disclosed are vectors produced using the plasmid, methods for producing the vectors, methods for treating mammals suffering from tumors and pharmaceutical formulations for use in the treatment methods. | 2010-05-13 |
20100120898 | MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma - Provided herein are methods and compositions for the diagnosis, prognosis and treatment of Hepatocellular carcinoma (HCC). Also provided are methods of identifying anti-HCC agents. | 2010-05-13 |
20100120899 | Tumor Repressor Genes in the Prevention of Cancer - The present invention provides methods for the use of tumor repressor molecules as a prognostic screen for cancer, risk assessment, prognosis, treatment and prevention of cancer in a subject. Furthermore, this invention provides a method to identify new genes that are tumor repressors. | 2010-05-13 |
20100120900 | Methods And Sequences To Preferentially Suppress Expression of Mutated Huntingtin - Disclosed herein are methods and sequences to preferentially suppress the expression of the mutated huntingtin (“htt”) protein over expression of the normal htt protein. Also disclosed are methods comprising screening an individual for the heterozygous presence of one or more single nucleotide polymorphisms within the individual's Huntington's genes; administering nucleic acid molecules comprising nucleotide sequences that preferentially suppress the expression of amino acid sequences encoding for mutated huntingtin (“htt”) over suppressing the expression of amino acid sequences encoding for normal htt by targeting an area of a Huntington's disease gene that is heterozygous for the presence of one or more single nucleotide polymorphisms. | 2010-05-13 |
20100120901 | NOVEL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USE FOR SAME - A pharmaceutical composition comprising a pharmaceutical diluent and a compound of formula IV wherein R | 2010-05-13 |
20100120902 | STANDARIZED BIOACTIVE HERBAL EXTRACTS - The present invention relates to standardized extracts of | 2010-05-13 |
20100120903 | Anti-inflammatory agent - An anti-inflammatory agent which includes an oil-soluble licorice extract, prepared by subjecting at least one of a leguminous plant of the genus | 2010-05-13 |
20100120904 | NOVEL USE OF GENISTEIN - Use of genistein for the treatment and prevention of dry eye syndrome or LKC and corresponding compositions containing it. | 2010-05-13 |
20100120905 | SYSTEM AND METHOD FOR CONTROLLING GROWTH OF MICROORGANISMS WITH BROMINATED FURANONES - A method for inhibiting the growth of a microorganism using an effective amount of one or more of the following synthetic brominated furanones: (i) 4-bromo-5Z-(bromomethylene)-3-methylfuran-2-one; (ii) 3-(dibromomethyl)-5-(dibromomethylene)furan-2-one; (iii) 3-(bromomethyl)-5-(dibromomethylene)furan-2-one; (iv) 4-bromo-3-(bromomethyl)-5Z-(bromomethylene)furan-2-one; or (v) 4-bromo-5-(dibromomethyl)-3-methylfuran-2(5H)-one. The brominated furanones inhibit the growth of both fungi and bacteria, including the fungal species | 2010-05-13 |
20100120906 | MODIFIED RELEASE FORMULATION AND METHODS OF USE - A modified release pharmaceutical formulation includes about 30-70% N-(2-amino-4-(fluorobenzylamino)-phenyl)carbamic acid ethyl ester (retigabine), or a pharmaceutically acceptable salt, solvate or hydrate thereof, about 5-30% of a drug delivery matrix including hydroxypropylmethylcellulose (HPMC), about 1.0-10% of an anionic surfactant, and an enteric polymer. The pharmaceutical formulation produces a sustained plasma concentration of retigabine following administration to a subject for 4-20 hours longer than the time required for in vitro release of 80% of retigabine. A formulation includes about 30-70% N-(2-amino-4-(fluorobenzylamino)-phenyl)carbamic acid ethyl ester (retigabine), or a pharmaceutically acceptable salt, solvate or hydrate thereof, about 5-30% of a drug delivery matrix, and an agent for retarding release in the gastric environment. The plasma concentration vs. time profile of this formulation is substantially flat over an extended period lasting for about 4 hours to about 36 hours. A method of treating a disorder characterized by nervous system hyperexcitability includes administering to a subject an effective amount of these pharmaceutical formulations. | 2010-05-13 |
20100120907 | DERIVATIVES OF AMYRIS ALCOHOLS AND EUDESMOL FOR TREATING COLD SORES AND HERPES - Provided are topical formulations comprising an Amyris alcohol and/or ester derivatives of Amyris alcohol which may be used for the treatment of diseases including herpes virus infection (e.g., HSV-1, HSV-2), epidermoid carcinoma, cold sores, and human papillomavirus. Amyris alcohols contemplated for use with the present invention include valerianol, beta-eudesmol, epi-gamma-eudesmol, elemol, alpha-eudesmol, and ester derivatives thereof. | 2010-05-13 |
20100120908 | EYE DROP PREPARATION COMPRISING LATANOPROST - Disclosed is an eye drop preparation comprising latanoprost, which is characterized in that the degradation of latanoprost in water can be prevented, the adsorption of latanoprost onto a plastic container can be prevented, and therefore the decrease in the latanoprost content can be prevented satisfactorily. The eye drop preparation comprises an eye drop composition comprising the following components (A)-(B) and packed in a plastic container: (A) latanoprost; and (B) a nonionic surfactant. | 2010-05-13 |
20100120909 | COMPOSITION BASED ON SUBSTITUTED 1,3-DIPHENYLPROP-2-EN-1-ONE DERIVATIVES, PREPARATION AND USES THEREOF - The invention concerns compositions comprising substituted 1,3-diphenylprop-2-en-1-one derivatives designed for therapeutic use. The inventive compositions are useful in particular for preventing or treating cardiovascular diseases, syndrome X, Ia restenosis, diabetes, obesity, hypertension, inflammatory diseases, cancers or neoplasms (benign or malignant tumors), neurodegenerative, dermatological diseases and disorders related to oxidative stress, for preventing or treating the effects of ageing in general and for example skin ageing, in particular in the field of cosmetics (occurrence of wrinkles and the like). | 2010-05-13 |
20100120910 | Cosmetic Compositions Comprising Esters Based on 2-Propylheptanol - The invention relates to the use of esters of 2-propylheptanol with benzoic acid and/or benzoic acid derivatives in cosmetic and/or pharmaceutical preparations. The compounds are distinguished by their particularly light sensory impression. | 2010-05-13 |
20100120911 | PRESERVATIVE SYSTEM FOR COSMETIC FORMULATIONS - Disclosed is a novel method for preserving cosmetic/personal care formulations through a two component preservative system, said system comprising (a) Component I which functions to eliminate the existing microbial contamination load in a natural cosmetic formulation base through an optimized pasteurization method that avoids deep freezing; and (b) Component II that includes the step of adding synergistic blends of fractionated essential oils, extracts and isolated compounds to the pre-pasteurized cosmetic base obtained through the method of component I, wherein the synergistic blends sustain the effects of pasteurization through anti-microbial and anti-oxidant effects, said anti-oxidant effects enhancing further the anti-microbial effects by virtue of inhibiting lipid per oxidation that facilitates the undue proliferation of microbe. | 2010-05-13 |
20100120912 | Esters of capsaicinoids as dietary supplements - Provided are nutraceutical or dietary supplemental compositions comprising esterified capsaicinoids. The esterified capsaicinoids may converted to the active parent capsaicinoid compound following enzymatic or chemical hydrolysis. In various embodiments, these esterified capsaicinoids have a higher lipophilicity, lipid solubility and result in less irritation to the stomach than the parent capsaicinoid, and hence may be included in certain dietary supplement formulations, including capsules, pills and tablets dietary supplement formulations. The dietary supplement compositions may be used for pain management in mammals in vivo and/or in the treatment of various pathological conditions in humans. | 2010-05-13 |
20100120913 | RESIN CATALYZED AND STABILIZED PERACID COMPOSITIONS AND ASSOCIATED METHODS - Methods, compositions, and system for making and stabilizing peracids in peracid-containing compositions are provided. The method of making can include the contacting of a cationic exchange resin with a carboxylic acid and hydrogen peroxide containing solution and maintaining the peracid in contact with the solution for a period of at least 24 hours to form a peracid. The solution to cationic exchange resin weight ratio used in the method is at least 10:1 w/w. The method of stabilizing can similarly include the maintaining the contact between the peracid-containing composition in contact with the cationic exchange resin during the storage of the peracid-containing composition. The methods and systems are particularly useful for peracid-containing disinfectant compositions. | 2010-05-13 |
20100120914 | MEDICAMENT FOR PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF HEPATIC STEATOSIS OR NON-ALCOHOLIC STEATOHEPATITIS - A medicament for prophylactic and/or therapeutic treatment of hepatic steatosis or non-alcoholic steatohepatitis, which comprises a polyprenyl compound (e.g., 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid) as an active ingredient. | 2010-05-13 |
20100120915 | Antimicrobials and related methods - Compositions for antimicrobial, antibacterial, antiviral, fungicidal and sporicidal applications comprise a mixture of alkyl betaine and alkyl amine oxide components together with a protonating agent. The compositions are particularly effective in the treatment and elimination of microorganisms in planktonic cell form as well as in sessile cell form in biofilms. The compositions may be applied in the form of sprays and foams as well as in liquid forms, as a solution or as a balm, as the sole active ingredient or with other active ingredients together with carriers or diluents. | 2010-05-13 |
20100120916 | THERAPEUTIC AGENT AND DIAGNOSTIC AGENT FOR MITOCHONDRIAL DYSFUNCTION BRAIN DISEASES - To provide a therapeutic agent and a diagnostic agent for mitochondrial dysfunction brain diseases including cerebral infarction as a representative. | 2010-05-13 |
20100120917 | BUTYLAMMONIUM MODULATORS OF FATTY ACID TRANSPORT - The present invention relates to new butylammonium modulators of fatty acid transport, and/or removal of toxic acyl-CoA compounds, pharmaceutical compositions thereof, and methods of use thereof | 2010-05-13 |
20100120918 | NOVEL NON-AQUEOUS TOPICAL SOLUTION OF DICLOFENAC AND PROCESS FOR PREPARING THE SAME - A non-aqueous topical solution composition of pharmaceutically acceptable salt of diclofenac is disclosed. The non-aqueous topical solution composition comprises therapeutically effective amount of pharmaceutically acceptable salt of diclofenac, solublizer, penetration enhancer and solvent, and optionally a humectant, counter irritant, additional penetration enhancer and anti-oxidants and a process for preparing the same. | 2010-05-13 |
20100120919 | METHODS FOR TREATING TRANSTHYRETIN AMYLOID DISEASES - Kinetic stabilization of the native state of transthyretin is an effective mechanism for preventing protein misfolding. Because transthyretin misfolding plays an important role in transthyretin amyloid diseases, inhibiting such misfolding can be used as an effective treatment or prophylaxis for such diseases. Treatment methods are disclosed. | 2010-05-13 |
20100120920 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) FOR THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH OXIDATIVE STRESS - Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione. | 2010-05-13 |
20100120921 | RENIN INHIBITORS FOR TREATMENT OF HYPERTENSION IN PATIENTS WITH HIGH SODIUM DIET - The present invention relates to methods for the prevention of, delay of progression to, or treatment of hypertension in a patient with a high sodium diet, comprising administering to such a patient a therapeutically effective amount of a renin inhibitor or a pharmaceutically acceptable salt thereof. | 2010-05-13 |
20100120922 | LIQUID FORMULATIONS CONTAINING A CAROTINOID - The present invention relates to a liquid formulation containing at least one carotenoid, at least one hydrophilic protective colloid and at least one water-miscible alcohol. The formulation according to the invention can be added directly to aqueous or non-aqueous preparations. The invention compositions can be used in animal feed, human food or a dietary supplement and in pharmaceutical and cosmetic preparations. | 2010-05-13 |
20100120923 | ADHESIVE COMPLEX COACERVATES AND METHODS OF MAKING AND USING THEREOF - Described herein is the synthesis of adhesive complex coacervates and their use thereof. The adhesive complex coacervates are composed of a mixture of one or more polycations and one or more polyanions. The polycations and polyanions in the adhesive complex coacervate are crosslinked with one another by covalent bonds upon curing. The adhesive complex coacervates have several desirable features when compared to conventional bioadhesives, which are effective in water-based applications. The adhesive complex coacervates described herein exhibit good interfacial tension in water when applied to a substrate (i.e., they spread over the interface rather than being beaded up). Additionally, the ability of the complex coacervate to crosslink intermolecularly increases the cohesive strength of the adhesive complex coacervate. The adhesive complex coacervates have numerous biological applications as bioadhesives and drug delivery devices. In particular, the adhesive complex coacervates described herein are particularly useful in underwater applications and situations where water is present such as, for example, physiological conditions. | 2010-05-13 |
20100120924 | NOVEL BASE FOR DRY SOLID DISPERSION, SOLID DISPERSION CONTAINING THE BASE, AND COMPOSITION CONTAINING THE DISPERSION - The present invention provides a novel base material for a dry solid dispersion, a solid dispersion containing the base material, and a composition containing the dispersion; the solid dispersion of the present invention, which contains a poorly soluble component with improved dissolvability, can be obtained by mixing a polyvinyl alcohol-based copolymer, as a base material for the dry solid dispersion, with a poorly soluble component, and then heating it. | 2010-05-13 |
20100120925 | ACIDIC ZIRCONIA SOL AND PRODUCTION METHOD OF THE SAME - There is provided an acidic zirconia sol having compatibility of particle properties and binding properties, and a production method of the same. The acidic zirconia sol includes zirconia particles (a) having a particle diameter ranging from 20 to 300 nm in a content of 90 to 50% by mass, based on the mass of all zirconia particles, and zirconia particles (b) having a particle diameter of less than 20 nm in a content of 10 to 50% by mass, based on the mass of all zirconia particles. | 2010-05-13 |
20100120926 | Processes for Gasification of a Carbonaceous Feedstock - The present invention relates to processes for preparing gaseous products, and in particular, methane via the catalytic gasification of carbonaceous feedstocks in the presence of steam. The processes comprise using at least one methanation step to convert carbon monoxide and hydrogen in the gaseous products to methane and do not recycle carbon monoxide or hydrogen to the catalytic gasifier. | 2010-05-13 |
20100120927 | FULLERENE BASED PROTON CONDUCTIVE MATERIALS - A fullerene-based proton conductor including a proton conductive functional group connected to the fullerene by an at least partially fluorinated spacer molecule. Also, a polymer including at least two of the proton conductors that are connected by a linking molecule. Further, an electrochemical device employing the polymer as a proton exchange membrane, whereby the device is able to achieve a self-humidifying characteristic. | 2010-05-13 |
20100120928 | MIX OF GRAFTED AND NON-GRAFTED PARTICLES IN A RESIN - In one application the mix grafted and non grafted invention provides for high thermal conductivity resin that comprises a host resin matrix | 2010-05-13 |
20100120929 | METHOD FOR PRODUCING HEAT-EXPANDABLE MICROSPHERES AND APPLICATION THEREOF - A production method for heat-expandable microspheres, which have high expanding ratio and are thermally expanded into hollow particulates having excellent repeated-compression durability, and application thereof are provided. The method produces heat-expandable microspheres a shell of thermoplastic resin and a blowing agent being encapsulated therein and having a boiling point not higher than the softening point of the thermoplastic resin. | 2010-05-13 |
20100120930 | USE OF LOW TRIPHENYLPHOSPHATE, HIGH PHOSPHOROUS CONTENT ISOPROPYL PHENYL PHOSPHATES AS FLAME RETARDANTS IN POLYURETHANE OR POLYISOCYANURATE FOAMS - The present invention relates to the use of low triphenyl phosphate, high phosphorous content aryl phosphates with high ortho alkylation as flame retardants in polyurethane or polyisocyanurate foams or polyurethane or polyisocyanurate foam formulations. | 2010-05-13 |
20100120931 | PRESSURE SENSITIVE ADHESIVES - A pressure sensitive adhesive formed from a blend of an acrylate polymer having at least one crosslinkable functional group, and a liquid oligomer having at least one crosslinkable functional group, wherein at least one of the acrylate polymer and the oligomer is crosslinked in the presence of the other. | 2010-05-13 |
20100120932 | POLYLACTIC ACID FOAM - A polylactic acid foam of beautiful appearance excelling in heat resistance and having satisfactory mechanical properties is provided from polylactic acid and a polyolefin resin and further a vinyl-carboxylate-modified polyolefin resin. The polylactic acid foam is characterized in that not only 1 to 80 parts by weight of polylactic acid but also vinyl-carboxylate-modified polyolefin is contained in 100 parts by weight of polyolefin resin containing 50 wt. % or more of polypropylene resin. | 2010-05-13 |
20100120933 | THERMOPLASTIC ELASTOMER COMPOSITION - Disclosed is a thermoplastic elastomer composition containing 10-60 parts by weight of a non-crosslinkable crystalline polyolefin resin (A), 1-30 parts by weight of a specific propylene 1-butene random copolymer (B) and 89-10 parts by weight of an ethylene α-olefin non-conjugated polyene copolymer rubber (C) which is composed of ethylene, an α-olefin having 3-20 carbon atoms and a non-conjugated polyene, in such amounts that the total of the components (A), (B) and (C) is 100 parts by weight. The thermoplastic elastomer composition is dynamically crosslinked by an extruder. This thermoplastic elastomer is excellent in moldability and economic efficiency, and enables to obtain a molded body exhibiting sufficient adhesion strength to a vulcanized rubber or thermoplastic elastomer without the intermediation of an adhesive layer, as well as a lightweight molded body having sufficient hardness and rubber elasticity. | 2010-05-13 |
20100120934 | BIOMATERIAL - The present invention provides a triblock copolymer and a viscoelastic biostable foam comprising the same. | 2010-05-13 |
20100120935 | BINDING AGENT - The present invention relates to binders, to processes for the preparation thereof, and to the use thereof in formulations, surface coatings, inks and plastics. | 2010-05-13 |
20100120936 | THERMALLY CURABLE PRECURSOR OF A TOUGHENED THERMO-EXPANDED FILM AND A FILM MADE THEREOF - Precursor of a toughened foamed film comprising a. 30-60 wt. % of at least one epoxy compound with an average epoxy equivalent weight of at least 350 g, b. 10-25 wt. % of at least one epoxy compound with an average epoxy equivalent weight of less than 200 g, c. 2-40 wt. % of at least one epoxy curing agent, d. 10-30 wt. % of at least one toughening agent, and e. at least one blowing agent wherein the mass ratio of the epoxy components a and b and the amount of the toughening component d is selected to provide a floating roller peel strength of the cured film of at least 150 N/25 mm at 23° C. and/or a shear impact strength of at least 12 kN/m | 2010-05-13 |
20100120937 | SEMICONDUCTOR DEVICE - Disclosed is a semiconductor device having a wafer level package structure which is characterized by containing a resin layer composed of a resin composition which is curable at 250° C. or less. Such a semiconductor device having a wafer level package structure is excellent in low stress properties, solvent resistance, low water absorbency, electrical insulation properties, adhesiveness and the like. | 2010-05-13 |
20100120938 | POLYSILOXANE COPOLYMERS WITH TERMINAL HYDROPHILIC POLYMER CHAINS - The invention provides an actinically-crosslinkable linear polysiloxane copolymer. The actinically-crosslinkable polysiloxane copolymer can be used to prepare a silicone hydrogel contact lens having a hydrophilic surface without post-curing surface treatment. The invention is also related to a silicone hydrogel contact lens obtained from a lens-forming material including an actinically-crosslinkable polysiloxane copolymer of the invention and to a method for making an actinically-crosslinkable polysiloxane copolymer of the invention. In addition, the invention provides a non-crosslinkable linear polysiloxane copolymer capable of being used as a internal wetting agent which can render the surface of a silicone hydrogel contact lens hydrophilic. | 2010-05-13 |
20100120939 | SILICONE HYDROGEL MATERIALS WITH CHEMICALLY BOUND WETTING AGENTS - The invention provide a new class of silicone-containing prepolymers containing ethylenically unsaturated groups and latent UV-activated free radical generating moieties. This class of silicone-containing prepolymer is capable of being actinically crosslinked in the presence of one or more hydrophilic vinylic monomers to form a silicone hydrogel material with a hydrophilic surface without post curing surface treatment. The present invention is also related to silicone hydrogel contact lenses made from this class of silicone-containing prepolymers and a vinylic monomer having a latent UV-activated free radical generating moiety. | 2010-05-13 |
20100120940 | PARTICULATE WATER-ABSORBING AGENT HAVING WATER-ABSORBING RESIN AS MAIN COMPONENT - A water-absorbing goods having excellent absorption performance in practical use is to be provided at low price. A particulate water-absorbing agent provided by one aspect of the present invention is a particulate water-absorbing agent comprising a polyacrylate salt-type water-absorbing resin as a main component, and satisfying the following (a) and (b):
| 2010-05-13 |
20100120941 | ADHESIVE AGENT FOR ADHESION BETWEEN ALGINATE IMPRESSION MATERIAL FOR DENTAL APPLICATIONS AND IMPRESSION TRAY, AND KIT COMPRISING THE ADHESIVE AGENT - To improve an adhesive force of an adhesive agent between an impression material and a tray, and to stabilize the adhesive force therebetween, provided is an adhesive agent for the adhesion between an alginate impression material and an impression tray for dental applications, which includes a polyamine compound having two or more amino groups in a molecule and a solvent. | 2010-05-13 |
20100120942 | SYNTHESIS OF METAL AND METAL OXIDE NANOPARTICLE-EMBEDDED SILOXANE COMPOSITES - Metal/metal oxide nanoparticle-embedded polymer films were synthesized in situ wherein the polymerizing agent was utilized for both reduction and polymerization (such as curing). This in situ method avoids the use of any external reducing agent/stabilizing agent and leads to a uniform distribution of nanoparticles in the polymer matrix. In some embodiments, additional heating can be utilized to form the nanoparticles embedded in the polymer film. | 2010-05-13 |
20100120943 | Starch-polyester biodegradable graft copolymers and a method of preparation thereof - A starch-polyester graft copolymer and chemically modified starch-polyester graft copolymer composition comprising a chemically modified starch or chemically modified starch-nanoclay product is described. The composition can be produced continuously in a twin-screw co-rotating extruder. The starch-polyester graft copolymer can be solvent cast, melt cast and blown into clear transparent film particularly for use in single use disposable applications and can be biodegradable. | 2010-05-13 |
20100120944 | USE OF CURABLE LIQUID ELASTOMERS TO PRODUCE GELS FOR TREATING A WELLBORE - A method of treating an earth formation that includes introducing at least one curable liquid elastomer composition in a liquid phase into the earthen formation; introducing at least one curing agent into the earthen formation; and contacting the curable elastomer composition and curing agent to form a non-aqueous gel is disclosed. | 2010-05-13 |
20100120945 | METHOD OF PRODUCING PIGMENT SUSPENSIONS - A method of producing a stable aqueous dispersion of a latex, solid particles and a dispersing agent, comprising contacting the latex with an anionic dispersing agent to form a modified latex, feeding the modified latex and the solid particles to a zone of high shear forces, and simultaneously subjecting essentially all of the modified latex and the solid particles fed to said zone to high shear forces to form a latex-particle slurry. By means of the invention, over 60 wt-% of the latex can be adsorbed on the solids. Latex immobilization increases the surface strength of final coating layer and allows for a decrease of latex consumption in paper and cardboard and paint applications. | 2010-05-13 |
20100120946 | Mitsubishi polyester film GmbH - The invention relates to biaxially oriented polyester films which contain 0.1-5.0% by weight (based on the weight of the film) of a hydrolysis stabilizer based on epoxidized fatty acid esters and 0.2-10% by weight (based on the weight of the film) of epoxidized fatty acid glycerides, the epoxidized fatty acid esters having a mean molecular weight of at least 425 g/mol. Such films find use in outdoor applications, as a ribbon cable, as a backside laminate of solar modules and in electrical insulation applications. | 2010-05-13 |
20100120947 | Biaxially stretched polyester film which comprises a chain extender, and process for production thereof and use thereof - The invention relates to biaxially oriented polyester films that include a chain extender in addition to polyester. Such films find use in all applications typical of biaxially oriented polyester films, especially in outdoor applications, as a ribbon cable, as a backside laminate of solar modules and in electrical insulation applications. | 2010-05-13 |
20100120948 | PROCESS FOR GRINDING AN AN AQUEOUS MEDIUM OF MINERAL MATTER AND BINDERS USING A REVERSE EMULSION OF A POLYMER ACRYLAMIDE WITH AN ACRYLIC MONOMER - The invention consists of a process for preparation of self-binding pigmentary particles, dry or in aqueous suspension or dispersion, using in a particular stage of the process a reverse emulsion formed from a dispersion in an oily phase of water particles and of at least one polymer of acrylamide with an acrylic monomer. | 2010-05-13 |
20100120949 | USE OF A FEED COMPOSITIONS IN PREPARATION OF METHACRYLIC ACID BY OXIDATION - The invention relates to a process for production of at least one C | 2010-05-13 |
20100120950 | Method for Manufacturing A Bis(Silatranylalkyl) Polysulfide, Method for Manufacturing a Mixture of Bis(Silatranylalkyl) Polysulfide etc., A Mixture of Bis(Silatranylalkyl) Polysulfide etc., and Rubber Composition - A method for manufacturing a bis(silatranylalkyl) polysulfide by heating a bis(trialkoxysilylalkyl) polysulfide and triethanolamine in the presence of a catalytic quantity of an alkali-metal alcoholate, thus substituting all Si-bonded alkoxy groups of the bis(trialkoxysilylalkyl) polysulfide with a (OCH | 2010-05-13 |
20100120951 | MONOAZO METAL COMPLEX, AZO-TYPE PIGMENT DISPERSANT, AND PIGMENT COMPOSITION COMPRISING THE AZO-TYPE PIGMENT DISPERSANT - [Problems] To microparticulate a yellow pigment having a structure derived from barbituric acid (e.g., C. I. Pigment Yellow 150) and increase the concentration of the pigment in a pigment composition comprising the pigment without increasing the viscosity of the composition after dispersion of the pigment, flocculation or precipitation in the composition, or increasing the viscosity of the composition over time; and to provide a stable pigment composition which can be used as a coloring agent for a color filter resist or a ink-jet ink.
| 2010-05-13 |
20100120952 | PHOSPHONATE CONTAINING TWO-COMPONENT COATING SYSTEM AND THE PRODUCTION AND USE THEREOF - The invention relates to two-component coating systems comprising as component (a) one or more polyisocyanates, as component (b) one or more oligomeric and/or polymeric compounds that are reactive with component (a), and as component (c) one or more phosphonates selected from the group of phosphonic diesters and diphosphonic diesters, where (i) component (b) comprises all oligomeric and/or polymeric compounds that are present in the two-component coating system and are reactive with component (a) and (ii) component (b) contains not more than 15% by weight, based on the total weight of component (b), of oligomeric and/or polymeric compounds which carry isocyanate-reactive amino groups. Additionally provided by the invention are a process for preparing the two-component coating systems, and the use of these coating systems as a clearcoat, more particularly for multicoat automobile finishing. | 2010-05-13 |
20100120953 | Highly Filled, Propylene-Ethylene Copolymer Compositions - Compositions comprising, based on the weight of the composition:
| 2010-05-13 |
20100120954 | Heavy Metal Deactivator/Inhibitor for Use in Olefinic Polymers - An olefine polymer composition comprises a stabilizing amount of a metal deactivator comprising a polymeric hydrazine derivative. The deactivator is of formula (I), in which at least one of R | 2010-05-13 |
20100120955 | Isocyanate, Diisocyanate and (Meth) Acrylate Compounds for Minimizing Scorch and Diisocyanate Compounds for Promoting Cure in Crosslinkable Compositions - Thermally activated, free-radical initiator-containing polymer compositions comprise a (i) free radical initiator, (ii) free radical crosslinkable polymer, (iii) scorch inhibiting amount and/or a cure-boosting amount of at least one of isocyanate, diiso-cyanate, e.g., MDI, or hydroxyalkyl(meth)acrylate compound, e.g., hydroxyethyl(meth)acrylate, and, optionally, (iv) other scorch retardants and/or cure boosters, e.g., a TEMPO compound, a hindered phenol, alpha-methyl styrene dimer, etc. The free radical initiator can be any thermally activated compound that is relatively unstable and easily breaks into at least two radicals, e.g., a peroxide or azo initiator. The crosslinkable polymer is a thermoplastic and/or elastomeric polymer that can be crosslinked (cured) through the action of a crosslinking agent, e.g., LDPE. The isocyanate, diisocyanate and (meth)acrylate scorch inhibitors and/or cure boosters can be used alone, or in combination with one another, or, optionally, in combination with a TEMPO compound, e.g., 4-hydroxy-TEMPO. | 2010-05-13 |
20100120956 | Method for Production of Natural Rubber - A method for producing a solid natural rubber by adding a compound having a quaternary ammonium ion and a carboxyl ion in the molecule thereof to a natural rubber latex and removing and drying a water content of the latex, whereby the increase in the viscosity during storage can be suppressed. | 2010-05-13 |
20100120957 | PROCESSES FOR MAKING COPOLYMERS USING MACROCYCLIC OLIGOESTERS, AND COPOLYMERS THEREFROM - The invention provides alternatives to traditional polycondensation processes for preparing copolymers. For example, in certain embodiments, the invention provides a process that includes an extrusion step and a solid state polymerization step to prepare high molecular weight block copolymer with a “hard block” contributed by a macrocyclic polyester oligomer (MPO) and a “soft block” contributed by a dihydroxyl-functionalized polymer, an oligoether, and/or a dimerized fatty acid (i.e. a polyol). The invention also provides new copolymer compositions made possible by the new processes—for example, copolymers of higher molecular weight, copolymers with higher weight ratio of soft block units to hard block units, copolymers made with higher molecular weight polyol, and copolymers with hard block units that are themselves random copolyesters of units contributed by a MPO and a cyclic ester. | 2010-05-13 |
20100120958 | Heat stabilized polyamide moulding composition - A polymer composition having improved heat stability is provided. The transition metal ion-modified clay can greatly increase the heat stability of the polymer especially the polyamide, with low cost. | 2010-05-13 |
20100120959 | POLYMER COMPOSITION CONTAINING HEAT STABILIZER - A use of transition metal ion-modified clay as a heat-stabilizer in a polymer is provided. The transition metal ion-modified clay can greatly increase the heat stability of the polymer especially the polyamide, with low cost. | 2010-05-13 |
20100120960 | METHOD FOR PRODUCTION OF SILVER-CONTAINING NANO-STRUCTURE, AND SILVER-CONTAINING NANO-STRUCTURE - Disclosed is a method for producing a silver-containing nanostructure which can reduce the time required for a post treatment step and the amount of a waste material and which is achieved by the application of the reduction reaction of silver oxide; and a silver-containing nanostructure having a specific structure, which can be produced by the method. Specifically disclosed is a method for producing a silver-containing nanostructure, including dispersing a polymeric compound in which a hydrophilic segment is bonded to a polyalkyleneimine chain in a medium, adding silver oxide thereto, and carrying out a reduction reaction of the silver oxide, thereby obtaining a silver-containing nanostructure. In the method, a structure having a branched structure can be produced when a specific compound is used as a complexing agent. The silver-containing nanostructure thus produced can be used as a conductive paste or the like. | 2010-05-13 |
20100120961 | POLYAMIDE RESIN COMPOSITION - A polyamide resin composition comprising a polyamide (X) having a diamine constituent unit which is mainly composed of a m-xylylenediamine unit and a dicarboxylic acid constituent unit which is mainly composed of an adipic acid unit; and specific amounts of a phosphorus acid antioxidant and alkaline component. The polyamide (X) is characterized by a specific range of terminal-group concentration balance and a specific amino-group reaction rate. This composition can simultaneously achieve inhabitation of yellow discoloration and reduction of number of gels or fish eyes. | 2010-05-13 |
20100120962 | Conditioner for electroless plating - A conditioner, surface treatment method, and metal plating film forming method for a moist method of providing a plating film with strong adhesion towards a surface with low roughness without forming a metal film or performing an adhesion promoter pretreatment using a wet method, when plating a resin substrate containing a blend of resin material and glass material, and the like. | 2010-05-13 |
20100120963 | LONG-FIBER REINFORCED POLYOLEFIN COMPOSITION - Disclosed are a long-fiber reinforced and colored molded article having desirable physical properties such as superior impact strength, tensile strength, and flexural strength as well as superior heat-resistance, a long-fiber reinforced polyolefin composition for producing the article, and method for producing the article. The long-fiber reinforced polyolefin composition comprises long-fiber reinforced polyolefin pellets including 35 to 90 weight % of a long-fiber reinforcing agent and 5 to 60 weight % of polyolefin wherein the impregnation degree of the long-fiber reinforced polyolefin pellet is preferably more than 80%; and colored polyolefin pellets having the length of 5 to 500 mm, and including 0.01 to 15 weight % of a coloring agent for the total amount of the coloring agent and polyolefin, wherein the amount of the colored polyolefin pellets is 5 to 80 weight % for the total amount of the colored polyolefin pellets and the long-fiber reinforced polyolefin pellets. | 2010-05-13 |
20100120964 | Composite Sheet With Visible Filler And Manufacturing Method - A solid surface sheet includes visible, elongated, shredded cuttings uniformly distributed throughout a matrix wherein the cuttings and the matrix have substantially the same specific weight and wherein a majority of the cuttings are substantially elongated. Related methods are also disclosed including shredding a first mix while in a gel state, curing the cuttings, sorting by size, and using as a filler in a base material to form a blend having a unique appearance and high internal strength. The preferred material is polyester or acrylic. The solid surface sheet can be used as a countertop, floor or wall panel, furniture, and in similar applications. | 2010-05-13 |
20100120965 | Optical Organic-Inorganic Composite Material and Optical Element - Provided are an optical organic-inorganic composite material exhibiting excellent transparency with respect to light having a short wavelength of around 405 nm and an optical element fitted with the optical organic-inorganic composite material, and sufficiently improving temperature dependence of the optical property (refractive index) by utilizing a resin with which an optical element is prepared at low coat in comparison to a glass material. Disclosed is an optical organic-inorganic composite material comprising inorganic particles possessing a composite oxide in which at least two kinds of metal oxides are incorporated, the inorganic particles dispersed in a resin in a state of primary particles or in a state where the plural number of primary particles are coagulated, wherein the dispersed particles have a refractive index variation standard deviation σ of 0.03 or less, and the inorganic particles have an average primary particle diameter of 1-50 nm. | 2010-05-13 |
20100120966 | Cellulosic-Thermoplastic Composite and Method of Making the Same - Provided is a composition comprising fatty acid bis-amide, inorganic particulate such as pumice, cellulosic particulate, thermoplastic and maleic anhydride grafted polyolefin. The combination of an ethylene bis-amide and a minor amount of pumice produces cellulosic-thermoplastic composite that has superior extrusion properties over conventional metal stearate/ethylene bis-stearamide (EBS) compositions such as improved flex strength and resistance to water absorption. | 2010-05-13 |
20100120967 | POLYESTER, AND COMPOSITION AND FILM COMPRISING THE SAME - An object of the present invention is to provide a polyester film having excellent dimensional stability to temperature and humidity. | 2010-05-13 |
20100120968 | WETTING AND SURFACE TENSION REDUCING AGENT - The present invention relates to a surface tension modifier for use in liquid curable composite materials, wherein the modifier is the reaction product between a polyol and an organo-functional silane. The present invention also relates to a method for producing a fibre reinforced composite material, and a fibre reinforced composite material when produced by the method. The method comprises the steps of contacting a plurality of reinforcing fibres with a curable resin mixture and curing the curable resin mixture, wherein the curable resin mixture comprises a curable resin and a predetermined quantity of the surface tension modifier of the invention. The present invention further relates to a method of improving wettability of a resin and use of the surface tension modifier of the invention. | 2010-05-13 |
20100120969 | CONTINUOUS, CARBON-NANOTUBE-REINFORCED POLYMER PRECURSORS AND CARBON FIBERS - The present invention relates to a continuous, carbon fiber with nanoscale features comprising carbon and carbon nanotubes, wherein the nanotubes are substantially aligned along a longitudinal axis of the fiber. Also provided is a polyacrylonitrile (PAN) precursor including about 50% to about 99.9% by weight of a melt-spinnable PAN and about 0.01% to about 10% of carbon nanotubes. Other precursor materials such as polyphenylene sulfide, pitch and solution-spinnable PAN are also provided. The precursor can also include a fugitive polymer which is dissociable from the precursor polymer. | 2010-05-13 |
20100120970 | REVERSIBLE MICELLES AND APPLICATIONS FOR THEIR USE - The present invention relates to novel (AB) block copolymers for use in coating surfaces to provide self-cleaning surfaces and capture/release materials wherein the copolymers comprises a first hydrophobic block (A) comprising a polymer selected from the group consisting of: a homopolymer of a fluorinated acrylate or methacrylate monomer (A1); a random, alternating, gradient or block copolymer, (A1A2) comprising: a fluorinated acrylate or methacrylate monomer (A1); and a non-fluorinated acrylate or methacrylate monomer (A2); a random, alternating, gradient or block copolymer, (A1A2) comprising: a fluorinated acrylate or methacrylate monomer (A1) and a silyl acrylate or methacrylate monomer (A3); and a random, alternating, gradient or block copolymer, (A1A2A3) comprising: a silyl acrylate or methacrylate monomer (A1), a fluorinated acrylate or methacrylate monomer (A2) and a non-fluorinated acrylate or methacrylate monomer (A3); and a second hydrophilic block (B) comprising a non-fluorinated acrylate or methacrylate monomer. | 2010-05-13 |
20100120971 | COMPOSITION FOR AQUEOUS COATING MATERIAL AND PROCESS FOR ITS PRODUCTION, AND TWO-COMPONENT CURABLE AQUEOUS COATING MATERIAL KIT - A composition for aqueous coating material which has a low content of an organic solvent and presents little burden on the environment and which is excellent in storage stability. | 2010-05-13 |
20100120972 | COMPOSITE COMPOSITIONS INCLUDING SEMI-AROMATIC POLYAMIDES AND CARBON FIBER, AND ARTICLES THEREOF - Disclosed is a thermoplastic composite composition including at least one semi-aromatic polyamide; a surface-treated carbon fiber having an aromatic sizing; optionally, from 0 to about 25 wt % PTFE; wherein the surface-treated carbon fiber has less than 1.0 wt % weight loss at 380° C., as measured by thermo-gravimetric analysis in air at 10° C./min. | 2010-05-13 |
20100120973 | STORAGE-STABLE, HYDROXY-MODIFIED MICROGEL LATICES - A composition is described, encompassing a constituent selected from the group consisting of a modified resin acid (I), a fatty acid (II) and a mixture composed of a modified resin acid (I) and of a fatty acid (II), where the degree of neutralisation of the constituent is from 104 to 165%. Its use for the production of microgels is also described. | 2010-05-13 |
20100120974 | COPOLYMER AND USE THEREOF - This invention relates a copolymer (D) containing (A) methacrylic polymer units each having, at an end thereof, at least one group represented by the below-described formula (1) and (B) units of an aromatic vinyl monomer, wherein a weight ratio (A:B) of the units (A) to the units (B) is A:B=5 to 95:95 to 5; and its use. The present invention can provide inter alia a copolymer useful as a pigment dispersant or the like capable of affording pigment dispersions useful for inkjet inks, colors for color filters, and other applications. | 2010-05-13 |
20100120975 | EPOXY SILICONE AND PROCESS FOR PRODUCING SAME, AND CURABLE MIX COMPOSITION USING SAME AND USE THEREOF - An epoxy silicon, which comprises at least a compound represented by the following general formula (1), and a compound represented by the following general formula (2); and which is represented by an average composition formula (3), wherein a value of [g/(a+b+c+d+e+f+g+h+i+j)] falls within a range of 0.020 or less. | 2010-05-13 |
20100120976 | AMINE FUNCTIONALIZED POLYMERS - A functionalized polymer includes a polymer chain and, bonded thereto, an functional group having the general formula —NHAR | 2010-05-13 |
20100120977 | ACCELERATOR SOLUTION - The invention relates to an accelerator solution comprising a complexing agent selected from the group consisting of complexing agents having a nitrogen atom and a hydroxyl group and bipyridine, a salt of a metal selected from the group consisting of transition metal, magnesium, and lithium, and optionally a solvent, wherein when the complexing agent has a nitrogen atom and a hydroxyl group, the amount of complexing agent in the accelerator solution is at least 5 wt %, based on the total weight of the accelerator solution, the amount of solvent is less than 50 wt %, and the amount of diethylene glycol as solvent is less than 25 wt %, based on the total weight of the accelerator solution. | 2010-05-13 |
20100120978 | BRANCHED POLYESTER FOR POWDER COATINGS - The present invention relates to a carboxylic acid functional branched polyester, having an acid number of at least 77 mg KOH/g, said carboxylic acid functional branched polyester being the reaction product of a polybasic organic carboxylic acid or its anhydride, preferably trimellitic anhydride, and a branched hydroxyl functional polyester obtained from 70 to 100 mole % of terephthalic acid and/or isophthalic acid and, optionally, from 0 to 30 mole % of another polycarboxylic acid, referring to the polyacid constituents, from 10 to 50 mole % of ethylene glycol, from 50 to 87.5 mole % of at least one other aliphatic or cycloaliphatic diol and from 1.5 to 15 mole % of at least one polyol, referring to the polyol constituents, as well as to the use of this polyester to prepare powder coating compositions which present a low gloss, especially of below 35% (at 60°), when used in combination with standard powder coating polyesters and crosslinkers. | 2010-05-13 |
20100120979 | Film(s) and/or sheet(s) comprising polyester compositions which comprise cyclobutanediol and have a certain combination of inherent viscosity and high glass transition temperature - Described are film(s) and/or sheet(s) comprising polyesters comprising (a) a dicarboxylic acid component having terephthalic acid residues; optionally, aromatic dicarboxylic acid or aliphatic dicarboxylic acid residues; 2,2,4,4-tetramethyl-1,3-cyclobutanediol residues; and 1,4-cyclohexanedimethanol residues. | 2010-05-13 |
20100120980 | FLUOROALKYL ETHER SULFONATE SURFACTANTS - A compound of Formula (1) | 2010-05-13 |
20100120981 | ETHYLENE COPOLYMER AND A METHOD OF PREPARING THE SAME - Provided are ethylene copolymers and a process for preparing the same. More specifically, provided are ethylene copolymers exhibiting excellent processibility and physical properties due to its multimodal molecular weight distribution index, through a multi-stage process by using reactors connected in series or in parallel in the presence of catalyst composition containing transition metal catalyst, and a process for preparing the same. | 2010-05-13 |
20100120982 | POLYMER-FACTOR IX MOIETY CONJUGATES - Conjugates of a Factor IX moiety and one or more water-soluble polymers are provided. Typically, the water-soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided (among other things) are compositions comprising the conjugates, methods of making the conjugates, and methods of administering to a patient compositions comprising the conjugates. | 2010-05-13 |
20100120983 | STYRENE/ANHYDRIDE POLYMERIC MATERIAL AND GRAFT HAVING ENHANCED PROPERTIES - A polymeric material from the styrene family, consisting of macromolecular chains grafted by nitrogen-containing heterocyclic groups; wherein the macromolecular chains consist of a polymeric backbone to which a grafted agent is attached by at least one covalent bond, the grafting agent comprises, in a single molecule, one or more associative groups capable of being bound by hydrogen bonds, and one or more reactive groups capable of forming covalent bonds with the polymeric backbone, at least one of the associative groups of the modifier is an imidazolidone heterocyclic ring. The mean number of imidazolidone groups to be inserted into the macromolecular chains is dependent both on the mean mass of said chains and on the final properties to be imparted to the material. The polymeric material of the invention can be extruded, coextruded, injected, blow-moulded, moulded, overmoulded, calendered or thermoformed. Objects such as tubes, films, plates, stiffenerss, bottles and containers can be made. The polymeric material of the invention can also be blended with other materials such as other polymers, and can thus be modified by elastomeric phases that enhance the impact strength thereof. The polymeric material of the invention can be a component of masterbatches of additives such as pigments and fillers. The present invention further relates to the use of said polymeric material as a compatibilization agent in a composition including, inter alia, at least two polymers belonging to different polymeric classes.” | 2010-05-13 |
20100120984 | PROCESS FOR PRODUCTION OF SURFACE-MODIFIED POLYMER STRUCTURES - The present invention relates to a process for producing a polymer structure comprising: mixing and unifying a matrix polymer made of a linear polymer and a highly-branched polymer having hydrophilic functional groups at molecular ends and to form a structure containing the matrix polymer and the highly-branched polymer; and subjecting the obtained structure to either immersion in water and/or a hydrophilic solvent or exposure to an atmosphere of vapor of water and/or a hydrophilic solvent at a temperature ranging from a temperature lower than Tg of the matrix polymer by 30° C. to decomposition temperature of the matrix polymer; wherein the hydrophilic functional groups at the molecular ends of the highly-branched polymer are distributed in outermost surface of the polymer structure at an enhanced density. The present invention also relates to a process for producing a polymer structure in which vinyl polymer chains are grafted to at least a part of the hydrophilic functional groups. | 2010-05-13 |
20100120985 | PROCESS FOR PRODUCING POLYMERIC OBJECT HAVING MICROPHASE-SEPARATED STRUCTURE AND POLYMERIC OBJECT HAVING MICROPHASE-SEPARATED STRUCTURE - A process for producing a polymeric object having a microphase-separated structure that can improve the degree of freedom for the structure to be formed is provided. A block copolymer composed of two or more segments and having a first segment composed of a monomer unit having a first functional group capable of forming an ionic bond and/or a hydrogen bond and a second segment incompatible with the first segment, and a polymer having, at other than the terminals of its polymer chain, a second functional group capable of forming an ionic bond and/or a hydrogen bond with the first functional group are mixed. Then, allowing the first segment to be associated with the polymer at many points by an ionic bond and/or a hydrogen bond, the mixture of the copolymer and the polymer is microphase separated. As a result, a polymeric object is formed including a region including the first segment and the polymer that have been associated with each other, and a region including the second segment. | 2010-05-13 |
20100120986 | PROCESS FOR THE PRODUCTION OF AQUEOUS BINDER LATICES - A process for the production of aqueous binder latices by multistage emulsion polymerization in the aqueous phase, comprising the successive steps:
| 2010-05-13 |